NCT03277430 - Uterus Transplantation From Live Donors and From Deceased Donors - Clinical Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 9, 2015

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2025

Conditions

Mayer Rokitansky Kuster Hauser SyndromeMullerian AplasiaUterus; Absence, CongenitalInfertility, FemaleUterus Absence, AcquiredAbsolute Uterine Factor Infertility

Interventions

PROCEDURE

Live donor uterus transplantation

Transplantation of uterus from a living donor.

PROCEDURE

Deceased donor uterus transplantation

Transplantation of uterus from a deceased brain-dead donor.

DRUG

Tacrolimus

Maintenance immunosuppression in UTx recipient will be reduced to tacrolimus monotherapy to minimalize fetal compromise.

Trial Locations (1)

14021

RECRUITING

Institute for Clinical and Experimental Medicine, Prague

All Listed Sponsors

collaborator

University Hospital, Motol

OTHER

collaborator

Sahlgrenska University Hospital

OTHER

lead

Institute for Clinical and Experimental Medicine

OTHER_GOV